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LETTER TO THE EDITOR
Genome-wide screening using genotyping microarrays and next-generation sequencing has discovered genomic rearrangements associated with clinical outcome of pediatric acute lymphoblastic leukemia (ALL). 1 These findings have increased our understanding of pediatric ALL and have contributed to the identification of new molecular markers for diagnosis and risk stratification. 2, 3 Recently, we discovered a novel PAX5-ESRRB fusion transcript by RNA-sequencing in a single B-cell precursor acute lymphoblastic leukemia (BCP ALL) patient (GEOID: ALL_619) cytogenetically karyotyped with non-recurrent chromosomal aberrations, denoted "other". 4 The 5'-partner in this fusion gene is PAX5 [chr9p13], which encodes an essential B-cell transcription factor with a conserved DNA-binding motif known as the paired box. Paired box transcription factors are crucial regulators of tissue development and early cellular differentiation, and alteration of their expression is thought to promote tumorigenesis. 5, 6 Deletions, amplifications and rearrangements involving PAX5 occur in ~40% of pediatric BCP ALL cases.
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The Estrogen-Related Receptor Beta gene (ESRRB) [chr14q24] is a previously unknown 3'-fusion partner of PAX5, which encodes a protein similar to the estrogen receptor. ESRRB is an orphan nuclear receptor with an unknown endogenous ligand. It mediates self-renewal and pluripotency in embryonic stem cells, and is able to reprogram somatic cells to a pluripotent state by upregulating embryonic stem cell-specific genes. 10 Alterations of ESRRB have been implicated in impaired placental development and aberrant metabolic function in mice, however little is known regarding its role in cancer and it has not been previously associated with ALL.
Using 450k DNA methylation array data (GEO:GSE49031) 12 available for ALL_619, copy number analysis (calculation of LogR from the probe signal intensities) revealed a deletion of chromosomal region 9p (chr9p) and a duplication of 14q (chr14q) corresponding to the PAX5-ESRRB fusion gene breakpoints. This suggested that the fusion resulted from an unbalanced t(9;14) rearrangement. To ascertain whether the PAX5-ESRRB fusion is recurrent in ALL, we screened 664 Nordic pediatric BCP ALL cases from the same dataset for concordant copy number changes on chr9p and chr14q. Three additional cases were identified with concordant deletions of chr9p and duplications of chr14q, within PAX5 and ESRRB respectively, totaling <1% (4/664) ( Table 1) . No additional cases were identified after screening 78 patients with cytogenetically unclassified BCP ALL by RNA-sequencing (data not shown).
To validate the findings from the methylation array, DNA from the four ALL cases was subjected to copy number analysis (CNA) on HumanOmni2.5M SNP arrays (Illumina, Inc).
The breakpoints on chr9p and chr14q within PAX5 and ESRRB were confirmed in all four cases, with the corresponding LogR and B-allele frequency values providing evidence of their presence in the dominant clone. The deletion of chr9p included the terminal region of PAX5, while the duplication on the distal region of chr14q suggested an unbalanced translocation on derivative chr9 (Supplementary Figures 1-2) . Although there were indications of an abnormal chr9p in ALL_757, the exact alteration could not be detected by G-banding. Using FISH, a der(9)t(9;14) rearrangement was verified in ALL_619 and ALL_757 ( Figure 1A ). Besides our earlier study where we report PAX5-ESRRB for the first time, 4 a single additional case with der(9)t(9;14)(p13;q24) was found in the literature, but with no information other than the karyotype available. 13 We identified two breakpoints in the Table 1 ). Table 2 ). Fusion of PAX5 exon 8 with ESRRB exon 5 (breakpoint 1) was confirmed in ALL_619, while a fusion between PAX5 exon 5 and ESRRB exon 5 (breakpoint 2) was confirmed in ALL_51, ALL_401 and ALL_757 ( Figure 1B ; Table 1 ). Both gene fusion variants were in-frame and predicted to produce a functional PAX5-ESRRB protein.
Expression of the PAX5-ESRRB
Regardless of the breakpoint, the fusion protein retains functionally important domains, such as the paired box domain, the highly conserved octapeptide motif for protein-protein interactions, and the nuclear localization signal of PAX5 ( Figure 1C Table 3 ). The observed ESRRB expression in ALL_619 derived from the retained ESRRB region in the der(9)t(9;14) translocation as seen in the RNA-sequencing data (Supplementary Figure 5) . Similarly, qRT-PCR analysis of ESRRB in the four PAX5-ESRRB cases showed expression of fused ESRRB compared to normal CD19+ B-cells
(Figure 2B). Expression of wt ESRRB was not detectable by qRT-PCR in any of the PAX5-ESRRB cases or in the CD19+ B-cells. Collectively, this suggests that expression of fused
ESRRB is driven by the translocated PAX5 promoter in cases with the der(9)t(9;14)
rearrangement, retaining key functional domains from both proteins.
Next, we used DNA methylation data to establish whether cases with the der(9)t(9;14)
acquire specific methylation changes. 12 Methylation data from the four PAX5-ESRRB cases was analyzed together with 24 additional ALL cases representing six cytogenetic subtypes of BCP ALL; dic(9;20), HeH, t(1;19)TCF3-PBX1, t(12;21)EVT6-RUNX1, t(9;22)BCR-ABL1
and 11q23/MLL (Supplementary Table 4 ). Six additional BCP ALL cases from the same DNA methylation data set known to harbor PAX5-ELN (n=1), PAX5-JAK2 (n=1), PAX5-ETV6 (n=2) or PAX5-ZCCHC7 (n=2), were also included. Using unsupervised hierarchical clustering across the 2000 most variable CpG sites, the der(9)t(9;14)PAX5-ESRRB cases formed a distinct cluster separated from the other subtypes including the other PAX5 chimeras ( Figure 2C ). We then interrogated differentially methylated CpG sites (DMCs) genome-wide between the PAX5-ESRRB group and the six BCP ALL subtypes. Based on a 6 maximum false discovery rate of 10% and an absolute mean methylation difference >20%, 825 CpG sites annotated to 648 unique genes were differentially methylated ( Figure 2D ;
Supplementary Table 5 ). The majority of the detected DMCs (96.8%) were hypomethylated in the der(9)t(9;14)PAX5-ESRRB group compared to the six BCP ALL subtypes ( Figure   2D ). Similarly, the identified DMCs were more hypomethylated in the PAX5-ESRRB group compared to PAX5-ELN, PAX5-JAK2 and PAX5-ZCCHC7, which clustered with the other BCP ALL subtypes. The PAX5-ETV6 cases were more hypomethylated and clustered close to the PAX5-ESRRB cases. Genes containing DMCs were enriched to the Wnt/Beta catenin pathway (p-value=2.25x10 ) and EBF1 (p-value 6,05x10 Figure 7) . Taken together, these analyses demonstrate that the der(9)t(9;14)PAX5-ESRRB, like other recurrent groups of BCP ALL, is associated with distinct molecular features.
This is the first study to describe the recurrence of a PAX5 fusion involving the estrogen related receptor ESRRB and its molecular characteristics in ALL. Although the cause for frequent PAX5 associated rearrangement is still unclear, it has become evident that PAX5 chimeras harbor diverse molecular features driven by the 3´partner gene. 14 BCP ALLs with PAX5-JAK2 fusions are known to display a different expression signature compared to other PAX5 fusions, characterized by upregulation of JAK-STAT target genes, suggesting that
PAX5 fusions interact not only with PAX5 target genes but also various downstream targets depending on the 3´partner. 2 Previously, we have demonstrated the utility of RNA-sequencing to detect novel fusion genes such as PAX5-ESRRB in childhood ALL. 4 Recently, the recurrence of a novel fusion gene, EP300-ZNF384, was first detected using RNA-sequencing and subsequently screened for by qRT-PCR. 15 By combining RNA-sequencing with CNA data from highdensity SNP arrays and HumanMethylation450BeadChips, we identified a group of rare cases harboring the same gene fusion within a large ALL cohort, in which screening by qRT-PCR would not be feasible. While genotyping arrays can be useful in screening for unbalanced rearrangements, such as the der(9)t(9;14), they are not suitable for detection of balanced rearrangements.
In conclusion, we describe the recurrent chromosomal rearrangement der(9)t(9;14)(p13.2;q24.3), an unbalanced translocation resulting in an in-frame fusion transcript involving PAX5 and ESRRB in four BCP ALL cases. We show that der(9)t(9;14)PAX5-ESRRB is associated with a distinct hypomethylated pattern compared to other BCP ALL subtypes including other PAX5 fusions analyzed herein. Whether patients with der(9)t(9;14)PAX5-ESRRB share additional biological or clinical features important for diagnosis and therapy warrants further investigation.
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(red) and chr14 (green) in ALL_619 and ALL_757. The structural rearrangement between chr9 and chr14 giving rise to the der(9)t(9;14)PAX5-ESRRB was verified in both cases. Cufflinks. Expression levels were measured as "fragments per kilobase of exon model per million mapped reads" (FPKM) using a pseudocount of +1 added to the data set, and plotted
on the y-axis as log 2 (FPKM+1). The observed ESRRB expression in ALL_619 represent the fused ESRRB region, as a result of the der(9)t(9;14)PAX5-ESRRB. Very low or no expression of ESRRB was detected in the BCP ALL group and in the normal controls. 
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Supplementary Figure 3 . Sanger sequencing traces across the fusion breakpoint (highlighted in yellow) between PAX5 and ESRRB for the four PAX5-ESRRB cases. In ALL_619 (upper panel), a fusion between exon 8 of PAX5 with exon 5 of ESRRB (breakpoint 1) was detected. In ALL_51, ALL_401 and ALL_757 (three lower panels), a fusion between exon 5 of PAX5 and exon 5 of ESRRB (breakpoint 2) was detected.
Expression of PAX5 (RNA-seq) 
Supplementary Figure 7.
(A) Gene ontology analysis was performed using the GREAT online tool to annotate DMCs to nearby genomic regions in respect to their biological functions. Enrichment of DMCs was found towards genes involved in hematopoiesis and lymphoid organ development. (B) Transcription factor (TF) binding motif analysis using the JASPAR database 2 was performed to annotate the DMC in relation to known binding sequences. A query window of 122 bp (+/-60bp from the DMC) was used to search for sequence patterns that are associated with the differentially methylated CpG. TF binding motifs are sorted by lowest p-value. Enrichment towards the early growth response gene-1 (EGR1) (p-value 3,68x10 -5 ) and early-B-cell factor gene (EBF1) (p-value 6,05x10 -5 ) binding motifs (yellow marked) was identified. Interestingly, EGR1 has been implicated as a tumor suppressor in leukemia as well as in B-cell development, a function that might be impaired by aberrant methylation across or in proximity to the binding motif.
4,5 EBF1 has been described as an important player for B lineage specification together with PAX5 and connected to PAX5 in a positive feedback loop. 
